Author: Pruss Rebecca M.
Publisher: Informa Healthcare
ISSN: 1746-0441
Source: Expert Opinion on Drug Discovery, Vol.6, Iss.8, 2011-08, pp. : 827-837
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The clinical developments and future of the COX-2 inhibitor drugs
Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. :
Sorafenib induces considerable muscular atrophy
Reactions Weekly, Vol. 1, Iss. 1289, 2010-01 ,pp. :